NO144850C - Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater. - Google Patents

Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater.

Info

Publication number
NO144850C
NO144850C NO764191A NO764191A NO144850C NO 144850 C NO144850 C NO 144850C NO 764191 A NO764191 A NO 764191A NO 764191 A NO764191 A NO 764191A NO 144850 C NO144850 C NO 144850C
Authority
NO
Norway
Prior art keywords
immunpotentating
preparation
glucosamine derivatives
analogy procedure
analogy
Prior art date
Application number
NO764191A
Other languages
English (en)
Norwegian (no)
Other versions
NO764191L (ru
NO144850B (no
Inventor
Gerhard Baschang
Jaroslav Stanek
Alex Sele
Albert Hartmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO764191L publication Critical patent/NO764191L/no
Publication of NO144850B publication Critical patent/NO144850B/no
Publication of NO144850C publication Critical patent/NO144850C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO764191A 1975-12-10 1976-12-09 Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater. NO144850C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (3)

Publication Number Publication Date
NO764191L NO764191L (ru) 1977-06-13
NO144850B NO144850B (no) 1981-08-17
NO144850C true NO144850C (no) 1981-11-25

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
NO764191A NO144850C (no) 1975-12-10 1976-12-09 Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater.

Country Status (30)

Country Link
JP (1) JPS5273820A (ru)
AR (2) AR224091A1 (ru)
AT (1) AT365607B (ru)
AU (1) AU508764B2 (ru)
BE (1) BE849214A (ru)
CA (1) CA1262400A (ru)
CH (2) CH613709A5 (ru)
CS (4) CS205025B2 (ru)
DD (1) DD129781A5 (ru)
DE (1) DE2655500A1 (ru)
DK (1) DK154654C (ru)
ES (2) ES454118A1 (ru)
FI (1) FI64164C (ru)
FR (1) FR2361902A1 (ru)
GB (1) GB1570625A (ru)
GR (1) GR61647B (ru)
HK (1) HK32883A (ru)
HU (1) HU177970B (ru)
IE (1) IE44190B1 (ru)
IL (1) IL51076A (ru)
MY (1) MY8400123A (ru)
NL (1) NL7613666A (ru)
NO (1) NO144850C (ru)
NZ (1) NZ182837A (ru)
PL (4) PL110787B1 (ru)
PT (1) PT65946B (ru)
SE (1) SE445923B (ru)
SG (1) SG11083G (ru)
SU (3) SU660589A3 (ru)
ZA (1) ZA767333B (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (de) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (ru) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
JP4875612B2 (ja) * 2005-04-27 2012-02-15 真司 武岡 カチオン性アミノ酸型脂質
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
EP3387005B1 (en) * 2015-12-10 2022-08-24 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
EP3672939A1 (en) 2017-08-21 2020-07-01 Celgene Corporation Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
IE44190B1 (en) 1981-09-09
FI64164C (fi) 1983-10-10
DE2655500A1 (de) 1977-06-23
FR2361902B1 (ru) 1980-11-07
CS205025B2 (en) 1981-04-30
PL112672B1 (en) 1980-10-31
IL51076A (en) 1980-09-16
SG11083G (en) 1983-09-16
PL110794B1 (en) 1980-07-31
FI64164B (fi) 1983-06-30
ATA909276A (de) 1981-06-15
HK32883A (en) 1983-09-02
DD129781A5 (de) 1978-02-08
DK154654B (da) 1988-12-05
AR220686A1 (es) 1980-11-28
CS205028B2 (en) 1981-04-30
CH613709A5 (en) 1979-10-15
SU1060118A3 (ru) 1983-12-07
CS205027B2 (en) 1981-04-30
AU508764B2 (en) 1980-04-03
AT365607B (de) 1982-02-10
CH614718A5 (en) 1979-12-14
IE44190L (en) 1977-06-10
DK154654C (da) 1989-05-08
MY8400123A (en) 1984-12-31
CA1262400A (en) 1989-10-17
HU177970B (en) 1982-02-28
CS205026B2 (en) 1981-04-30
BE849214A (fr) 1977-06-09
ES465514A1 (es) 1978-09-16
DK552476A (da) 1977-06-11
JPS638118B2 (ru) 1988-02-19
NO764191L (ru) 1977-06-13
SU660589A3 (ru) 1979-04-30
PT65946A (en) 1977-01-01
SE7613851L (sv) 1977-06-11
PT65946B (en) 1978-06-14
DE2655500C2 (ru) 1988-12-22
JPS5273820A (en) 1977-06-21
NO144850B (no) 1981-08-17
NL7613666A (nl) 1977-06-14
AU2042276A (en) 1978-06-15
AR224091A1 (es) 1981-10-30
NZ182837A (en) 1978-07-28
SE445923B (sv) 1986-07-28
FI763541A (ru) 1977-06-11
ES454118A1 (es) 1978-03-01
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
ZA767333B (en) 1977-11-30
PL110787B1 (en) 1980-07-31
SU747430A3 (ru) 1980-07-23
IL51076A0 (en) 1977-02-28
PL194291A1 (pl) 1978-10-23
PL110353B1 (en) 1980-07-31
FR2361902A1 (fr) 1978-03-17

Similar Documents

Publication Publication Date Title
NO144850C (no) Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater.
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
SE433208B (sv) Forfarande for framstellning av fenoletrar
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE7504842L (sv) Forfarande for framstellning av adeninderivat..
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
NO146141C (no) Fremgangsmaate til fremstilling av aminocyklitolantibiotika
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
NO153221C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6-metoksy-alfa-karboksypenicilliner.
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
AR211854A1 (es) Procedimiento de preparacion de derivados polisustituidos de 10-piperazinodibenzo(b,f)tiepina
NO811390L (no) Fremgangsmaate til fremstilling av 6,11-dihydro-11-oksodibenz(b,e)-oksepinalkansyrer
NO143626C (no) Fremgangsmaate til fremstilling av 2-alkyl-5-nitroimidazolderivater.
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7507482L (sv) Forfarande for framstellning av substituerade l-sulfonylbensimidazoler.
NO143534C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol.
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE386144B (sv) Forfarande for framstellning av en alkaliamid.
SE417967B (sv) Analogiforfarande for framstellning av reserpinderivat